Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

Clinical trial NCT06093191 · COMPLETED

Trial details

NCT number: NCT06093191
Sponsor: Jin-Fu Xu
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bronchiectasis Adult Pseudomonas Aeruginosa Infection

Start date: 2023-10-18
Primary completion: 2025-10-28
Enrollment: 371

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.